OnePass Medical

OnePass Medical develops a disposable platform for interventional endoscopy and bronchoscopy treatments. The company’s first product, InstaFAN, is a biopsy device for collecting multiple tissue samples from different areas of a tumor in a single procedure, enhancing diagnostic accuracy and reducing time and repeat biopsies. The platform is particularly strong for endoscopy-ultrasound guided biopsies and bronchoscopies and has potential to expand into therapeutic applications, including multipronged drug delivery and ablation. It is the only endoscopic platform capable of delivering multiple needles/probes simultaneously, advancing both diagnostic and therapeutic capabilities. OnePass has two ongoing strategic development collaborations with Mayo Clinic, both of which include licensing agreements. The first focuses on gastro-intestinal applications of the InstaFAN platform, where OnePass has demonstrated significant clinical efficacy through first-in-man experiences.

OnePass Medical has raised $3.47M in total funding across 3 rounds. The company is currently at the Seed stage. Key investors include G.O Innovation.

OnePass Medical was founded in 2018 by Jacob BenArie (Co-Founder, CEO & Managing Director), Jesse Yishai Lachter (Co-Founder & Inventor).

OnePass Medical operates in Health Tech & Life Sciences, Medical Devices, Diagnostics Devices, Medical Treatment & Therapeutics, with core technologies in Simulation & Imaging, Ultrasound. Target customers: Commerce & Retail, Distribution Channels, Distributor, Healthcare & Life Sciences, Healthcare, Providers.

OnePass Medical is based in HaHermon Road/Katsrin Industrial Zone, Qatsrin, North District.